id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0438-0008,FDA,FDA-2006-E-0438,"Certificate Extending Patent Term from U.S. Patent and Trademark Office to Browdy and Neimark, P.L.L.C.",Rule,Certificate Extending Patent Term,2007-04-23T04:00:00Z,2007,4,,,2025-12-15T21:54:19Z,,0,0,0900006480461e60
FDA-2006-E-0438-0007,FDA,FDA-2006-E-0438,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-01-10T05:00:00Z,2007,1,,,2025-12-15T21:50:10Z,,0,0,0900006480461e5f
FDA-2006-E-0438-0006,FDA,FDA-2006-E-0438,Determination of Regulatory Review Period for Purposes of Patent Extension; LUVERIS,Notice,General Notice,2006-08-07T04:00:00Z,2006,8,2006-06-12T04:00:00Z,2006-08-15T03:59:59Z,2025-12-15T21:43:39Z,,0,0,0900006480461e5d
FDA-2006-E-0438-0005,FDA,FDA-2006-E-0438,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-05-24T04:00:00Z,2006,5,,,2025-12-15T21:40:30Z,,0,0,0900006480461e5c
FDA-2006-E-0438-0004,FDA,FDA-2006-E-0438,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-05-23T04:00:00Z,2006,5,,,2025-12-15T21:34:06Z,,0,0,0900006480461e5a
FDA-2006-E-0438-0002,FDA,FDA-2006-E-0438,Number Not Used,Other,Letter(s),2006-02-28T05:00:00Z,2006,2,,,2025-12-15T19:26:59Z,,0,0,0900006480461e57
FDA-2006-E-0438-0003,FDA,FDA-2006-E-0438,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-02-28T05:00:00Z,2006,2,,,2026-01-13T18:43:31Z,,0,0,0900006480461e59
FDA-2006-E-0438-0001,FDA,FDA-2006-E-0438,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-01-12T05:00:00Z,2006,1,,,2025-12-15T19:21:54Z,,0,0,0900006480461e3e